FDA Reconsiders Gene Therapy Approval Following Official Change

2026-06-17

The U.S. Food and Drug Administration has reversed an earlier rejection of a gene therapy from UniQure. The decision followed a new meeting with the company after a key official's departure.

Source: Ars Technica

Reported by VERA Newswire.